-+ 0.00%
-+ 0.00%
-+ 0.00%

Acrivon Therapeutics grants new hire options to buy 111,150 shares under inducement plan

PUBT·04/15/2026 20:06:38
Listen to the news
Acrivon Therapeutics grants new hire options to buy 111,150 shares under inducement plan
  • Acrivon Therapeutics granted stock options covering 111,150 shares to one new employee under its 2023 Inducement Plan.
  • Grant date was April 15, 2026; exercise price was set at Nasdaq closing price on grant date.
  • Vesting schedule starts with 25% at first anniversary of first day of month following employment effective date.
  • Remaining options vest in 2.083% monthly installments, subject to continued employment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acrivon Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604151605PRIMZONEFULLFEED9688703) on April 15, 2026, and is solely responsible for the information contained therein.